Washington Issues RFP For Hepatitis C Medications With An Annual Spending Ceiling

On January 22, 2019, the Washington State Heath Care Authority (HCA) released a request for proposals (RFP 3233) seeking a contractor to provide direct acting antiviral medications for hepatitis C virus (HCV) for populations covered by a state agency health plan. The HCA purchase model is a fixed unit price with an annual maximum dollar threshold. If the volume of state medication orders in a year at the unit price reaches the maximum annual threshold, the contractor will provide additional medication units at minimal to no cost. The contractor will also provide public health outreach, link consumers to testing and . . .